Eye Yon
Tel-Aviv, IL · 2 known investors
Find your way into Eye Yon
Sign up to see every warm intro you have to Eye Yon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eye Yon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EyeYon Medical develops medical devices for corneal diseases, including EndoArt®, a synthetic implant for chronic corneal edema, and HyperCL™, a therapeutic contact lens for enhancing drug absorption in corneal conditions. The company serves ophthalmologists and patients requiring alternatives to traditional corneal transplantation.
Founders & leadership
Investors · 2
Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya
How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Triventureslisted by TriventuresHerzliya · $1M – $3M
How we know: the VCSheet dataset · Not right? Tell us
Founder mafia
2 people who came through Eye Yon went on to found or lead other companies.
Frequently asked questions
- What does Eye Yon do?
- EyeYon Medical develops medical devices for corneal diseases, including EndoArt®, a synthetic implant for chronic corneal edema, and HyperCL™, a therapeutic contact lens for enhancing drug absorption in corneal conditions. The company serves ophthalmologists and patients requiring alternatives to traditional corneal transplantation.
- Who founded Eye Yon?
- Eye Yon was founded by Nahum Ferera, Dr. Ofer Daphna, Prof. Arie Marcovich.
- Who are Eye Yon's investors?
- Eye Yon's investors include Pontifax Venture Capital, Triventures.
- Where is Eye Yon headquartered?
- Eye Yon is headquartered in Tel-Aviv, IL.



